𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer

✍ Scribed by Qi Wang; Zhi-Guo Chen; Chang-Zheng Du; Hong-Wei Wang; Li Yan; Jin Gu

Book ID
108780779
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
801 KB
Volume
55
Category
Article
ISSN
0309-0167

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CD133 and CD44 Cell surface markers do n
CD133 and CD44 Cell surface markers do not identify cancer stem cells in primary human gastric tumors
✍ Alba Rocco; Eleonora Liguori; Giuseppe Pirozzi; Virginia Tirino; Debora Compare; πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 403 KB

## Abstract Emerging evidence suggests that tumors contain and are driven by a cellular component that displays stem cell properties, the so‐called cancer stem cells (CSCs). CSCs have been identified in several solid human cancers; however, there are no data about CSCs in primary human gastric canc

CD133 and CD44 are universally overexpre
CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers
✍ Junwei Chen; Tianhua Guo; Lei Zhang; Li-Xuan Qin; Samuel Singer; Robert G. Maki; πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 495 KB

## Abstract Although imatinib mesylate has been a major breakthrough in the treatment of advanced gastrointestinal stromal tumors (GIST), complete responses are rare and most patients eventually develop resistance to the drug. Thus, the possibility of an imatinib‐insensitive cell subpopulation with

Epigenetic regulation of cancer stem cel
Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-Ξ²
✍ Hanning You; Wei Ding; C. Bart Rountree πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 463 KB πŸ‘ 1 views

Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. CD133, a transmembrane glycoprotein, is an important cell surface marker for both stem cells and cancer stem cells in various tissues including liver. CD133 expression has been recently linked to poor prognosis